Hitoe Torisu‐Itakura

Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma

Jonathan Lee, Richard Essner, Hitoe Torisu‐Itakura et al. · Journal of Clinical Oncology · 2004 · 173 citations · Full text

Co‐expression of Thymidine Phosphorylase and Heme Oxygenase‐1 in Macrophages in Human Malignant Vertical Growth Melanomas

Hitoe Torisu‐Itakura, Masutaka Furue, Michihiko Kuwano et al. · Japanese Journal of Cancer Research · 2000 · 84 citations · Full text

Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (<scp>UNCOVER</scp>‐J)

Yukari Okubo, Tomotaka Mabuchi, Keiji Iwatsuki et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 62 citations · Full text

Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients

Hitoe Torisu‐Itakura, Jonathan H. Lee, Young Huynh et al. · Journal of Immunotherapy · 2007 · 43 citations

Tumor Immunology, Il-10 Expression, Il-10 Levels +10

Efficacy and safety of ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis: Subgroup analysis of a placebo‐controlled, phase 3 study (UNCOVER‐1)

Shinichi Imafuku, Hitoe Torisu‐Itakura, Atsushi Nishikawa et al. · The Journal of Dermatology · 2017 · 42 citations · Full text